What did AFT Pharmaceuticals Limited announce?
AFT Pharmaceuticals Limited (NZX: AFT) filed “ScomaraTM Tentative Approval by US FDA” with NZX on 20 July 2026, as an operational update announcement.
- Which company?
- AFT Pharmaceuticals Limited (NZX: AFT)
- When was it filed?
- 20 July 2026
- Where is the original?
- NZX announcement
ScomaraTM Tentative Approval by US FDA
Full Text Not Available
The extracted text for this announcement is not yet available.
View Original PDFView on NZXAFT reports ongoing sales growth and R&D progressPitt St Research initiates coverage on AFT Pharmaceuticals
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.